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Plasmid-mediated quinolone resistance (PMQR) determinants including, qnrA,
qnrB, qnrC, qnrD, qnrS, aac(6′)-Ib-cr, oqxAB, and qepA, were investigated in 214
Enterobacteriaceae strains from urine clinical samples. Antimicrobial susceptibility
testing for ciproﬂoxacin, ceftriaxone, and imipenem was performed by broth micro-
dilution method. All strains were screened for PMQR genes by PCR. Virulence
determinants, namely afa, pap, pil, sfa/foc, and kpsMT of eight Escherichia coli strains
proven positive for at least one qnr gene, were investigated by PCR. All of the eight
investigated strains carried the pil gene, showing that P ﬁmbria is a common virulence
determinant among qnr positive E. coli. Out of 214 tested strains, 38 yielded any PMQR
determinant, altogether 45 genes were detected namely, 6 qnrA, 1 qnrB, 2 qnrD and
8 qnrS, 9 aac(6′)-Ib-cr, and 19 oqxAB; however, neither qepA nor qnrC were detected.
Notably, 18Klebsiella spp., harbored oqxAB, nine E. coliwere positive for qnrS and two
Morganella morganii yielded qnrD resistance determinant. In this study, we demon-
strated 17.7% prevalence of PMQR-positive Enterobacteriaceae and ﬁrst reported
qnrD-resistance determinant in Hungary. Altogether, 25 PMQR-positive strains were
susceptible or low-level resistant to ciproﬂoxacin with minimum inhibitory concentra-
tion (MIC) between 0.06 and 1 mg/L, suggesting that prevalence of PMQR determinants
is underestimated and screening among clinical isolates exhibiting reduced susceptibility
is necessary. Fluoroquinolone resistance breakpoints of Enterobacteriaceae were revised
in 2017 by European Committee of Antimicrobial Susceptibility Testing indicating
ciproﬂoxacin susceptibility only until 0.25 mg/L MIC value.
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Introduction
Plasmid-mediated quinolone resistance (PMQR) was ﬁrst described in 1998
and was named as Qnr determinant [1]. Since then, several lineges of Qnr have
been detected as transferable resistance mechanism, namely QnrA, QnrB, QnrC,
QnrD, QnrE, QnrS, and QnrVC. To date, numerous alleles of qnr genes were
identiﬁed and listed in www.lahey.com/qnrStudies homepage [2]. Besides Qnr
determinants, aminoglycosid-acetyltranferase (6′)-Ib-cr was also identiﬁed as a
plasmid-coded quinolone resistance determinant [3]. Furthermore, QepA and
OqxAB efﬂux pumps also belong to the transferable quinolone resistance
mechanisms [4, 5]. Each of the aforementioned resistance determinant confers
reduced susceptibility and low-level quinolone resistance in Enterobacteriaceae,
which is characterized by ciproﬂoxacin minimum inhibitory concentrations
(MICs) higher than the wild-type phenotype (0.06 mg/L), and reaching the
currently accepted resistance breakpoint (0.5 mg/L) by European Committee of
Antimicrobial Suscpetibility Testing (EUCAST) issued in 2017 [1].
Since the discovery of PMQRs, a worldwide distribution of these determi-
nants has been described in Enterobacteriaceae. The association of PMQRs with
beta-lactamases and with various resistance mechanisms was reported from
different countries [6]. Several plasmids and mobile genetic elements were
described as carriers of PMQR genes and additional resistance determinants.
Determinants of qnrA, qnrB, and qnrS are widely disseminated among Enter-
obacteriaceae. Transferable plasmid coding qnrB19, blaKPC-3 blaSHV-11, blaTEM-1,
and aac(6′)-Ib was detected in Klebsiella pneumoniae [7]; qnrS1 and blaVIM-1
coding conjugative plasmids were described in Klebsiella oxytoca [8]; qnrA1 and
blaVEB coding transferable plasmids in Enterobacter cloacae were detected [9];
plasmids coding for armA, qnrS1, aac(6′)-Ib-cr, blaCTX-M-15, blaTEM-1, and
blaNDM-1 were transferable from K. pneumoniae [10]; and conjugative plasmid
coding for qepA, rmtB, and blaTEM-1 was detected in Escherichia coli [11].
In the case of qnrC, it was ﬁrst detected in Proteus mirabilis on a
transferable plasmid; however, there have been no other reports released about
this determinant [12].
First qnrDwas detected in Salmonella spp., but later on, E. coli, P. mirabilis,
Morganella morganii, and Providencia stuartii were all found to carry this
resistance determinant [13–18]. Among clinical isolates, species of Proteae tribe
commonly carry qnrD on small, non-transferable plasmids [16–18]. Most recent-
ly, QnrE1 has been detected inK. pneumoniae. Studies suggest that qnrEwas most
likely to be located in chromosome of Enterobacter spp. and mobilized by ISEcp1
to plasmids of K. pneumoniae [19, 20].
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Materials and Methods
Strains
A total of 214 non-repetitive Enterobacteriaceae strains were collected
between 2013 and 2014 at Semmelweis University, Clinical Microbiology
Diagnostic Laboratory from urine clinical isolates, namely 99 E. coli, 36 Proteus
spp., 32 Klebsiella spp., 20 Enterobacter spp., 15 Serratia spp., 6 Citrobacter
spp., 5Morganella sp., and 1 P. stuartii. Identiﬁcation of strains was performed by
matrix-assisted laser desorption ionization time of ﬂight/mass spectrometry
(Bruker Daltonik GmbH, Bremen, Germany). Each strain exhibited either sus-
ceptible, reduced suscpetible, or resistant ﬂuoroquinolone phenotype based on
routine diagnostic procedure carried out by disk diffusion method.
Determination of MIC
Ciproﬂoxacin, ceftriaxone, and imipenem MIC values of strains were
determined by broth microdilution method by 96-well microplates and inter-
epreted after EUCAST documents issued in 2016 (www.eucast.org).
PMQR gene detection
Detection of PMQR genes was performed by PCR. DNA preparation was
carried out from each tested strain as colonies were incubated at 100 °C for
15 min in a total volume of 0.5 ml ultrapure distilled water (Millipore, Merck
KGaA, Darmstadt, Germany) followed by centrifugation of cell suspension at
13,000 rpm on 4 °C. Each PCR mixture contained 1× PCR buffer [10 mM
Tris–HCl (pH 8.3), 50 mM KCl], 1.5 mM MgCl2, 200 mM each deoxynucleo-
tide triphosphate, 20 pmol of each primer, and 1 U of Taq polymerase
(Sigma-Aldrich, St. Louis, MO, USA). Primers of this study are listed in
Table I. Screening for qnrA, qnrB, and qnrS was carried out by multiplex PCR
with speciﬁc primer pairs of qnrA-, qnrB-, and qnrS that ampliﬁed internal
fragments with sizes of 516, 540, and 417 bp, respectively, PCR thermal proﬁle
was as follows: 10 min at 95 °C and 32 cycles of ampliﬁcation consisting of
45 s at 94 °C, 45 s at 53 °C and 1 min at 72 °C, and an additional 10 min at
72 °C for the ﬁnal extension [21–23]. Simplex PCR for detection of qnrC and
qnrD with speciﬁc primers was performed with the following thermal proﬁle
94 °C for 5 min, 94 °C for 1 min, 50 °C for 1 min, and 72 °C for 1 min for
30 cycles; and 72 °C for 10 min, whereas 447 bp of qnrC and 550 bp of qnrD
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were ampliﬁed [12, 13]. The aac(6′)-Ib gene was ampliﬁed by PCR with speciﬁc
primers with following conditions: 94 °C for 45 s, 55 °C for 45 s, and 72 °C for
45 s for 34 cycles to produce a 482-bp product. All aac(6′)-Ib PCR positive
amplicons were further analyzed by digestion with BstF5I (New England Biolabs,
Ipswich, MA) to identify aac(6′)-Ib-cr, which lacks the BstF5I restriction site
present in the wild-type gene [24]. A 199-bp fragment of qepA was ampliﬁed by
PCR with qepA fwd and rev oligonucleotides wih following conditions: initial
denaturation at 96 °C for 1 min, followed by 30 cycles of ampliﬁcation at 96 °C for
1 min, annealing at 60 °C for 1 min, and extension at 72 °C for 1 min. The ﬁnal
extension step was at 72 °C for 5 min [25]. The oqxAB resistance determinant was
screened by PCR with speciﬁc oqxA fwd and rev and oqxB fwd and rev primers.
PCR conditions for oqxA were 94 °C for 45 s, 57 °C for 45 s, and 68 °C for 60 s
with a cycle number of 34, whereas in the case of oqxB, the thermal proﬁle was
94 °C for 45 s, 64 °C for 45 s, and 72 °C for 60 s with a cycle number of 32,
whereas 392 bp of oqxA and 512 bp of oqxB were ampiﬁed [5]. DNA fragments
were analyzed by electrophoresis in a 1.5% agarose gel (Sigma-Aldrich) at 120 V
for 20 min in 1× TAE [40 mM Tris–HCl (pH 8.3), 2 mM acetate, 1 mM EDTA].
Gel was stained by 0.05 mg/L Gelred dye (Biotum) and was evaluted by UV
transilluminator.
Table I. Primers used in the detection of PMQRs
Primer name Sequence Reference
qnrA fwd ATTTCTCACGCCAGGATTTG [3]
qnrA rev GATCGGCAAAGGTTAGGTCA
qnrB fwd ATGACGCCATTACTGTATAA [2]
qnrB fwd GATCGCAATGTGTGAAGTTT
qnrS fwd ACGACATTCGTCAACTGCAA [3]
qnrS rev TAAATTGGCACCCTGTAGGC
qnrC fwd GGGTTGTACATTTATTGAATC [12]
qnrC rev TCCACTTTACGAGGTTCT
qnrD fwd CGAGATCAATTTACGGGGAATA [13]
qnrD rev AACAAGCTGAAGCGCCTG
qepA fwd GCA GGT CCA GCAGCG GGT AG [24]
qepA rev CTT CCT GCC CGAGTA TCG TG
oqxA fwd CTCGGCGCGATGATGCT [5]
oqxA rev CCACTCTTCACGGGAGACGA
oqxB fwd TTCTCCCCCGGCGGGAAGTAC
oqxB rev CTCGGCCATTTTGGCGCGTA
aac-(6′)-Ib fwd TTGCGATGCTCTATGAGTGGCTA [25]
aac-(6′)-Ib rev CTCGAATGCCTGGCGTGTTT
Note: PMQRs: plasmid-mediated quinolone resistances.
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Detection of virulence determinants of E. coli
Tested virulence determinants of E. coli were the following: aﬁmbrial
adhesins (afa), S and F1C ﬁmbiriae (sfa/foc), pili associated with pyelonephritis
(pap), K-antigen (kpsMT), and P ﬁmbria (pil). Detection of virulence determinants
of eight E. coli strains, previously proven positive for at least one qnr gene, was
performed by PCR. Colonies of each tested E. coli strain were incubated in
ultrapure distilled water (Millipore) at 100 °C for 10 min in a total volume of
500 μl followed by centrifugation for 15 min at 13,000 rpm at 4 °C temperature.
After centrifugation, 200 ng DNA template of 3 μl of the supernatant was used in
PCR along with the following components: 1.25 U Taq DNA polymerase (Sigma-
Aldrich), 0.5 μM of each virulence determinant oligonucleotide primer (Table II),
0.2 mM dNTP mix (Sigma), 2.5 mM buffer Mg2+ (Sigma), in 50 μl total volume.
Ampliﬁcation was performed with the following protocol: 30 times of 94 °C for
1 min, 60 °C for 1 min, and 72 °C for 1.5 min, followed by an additional
elongation at 72 °C for 7 min. Amplicons were investigated by electrophoresis at
120 V for 25 min in a 1.5% agarose gel (Sigma-Aldrich) in a 1× TAE [40 mM
Tris–HCl (pH 8.3), 2 mM acetate, and 1 mM EDTA] buffer followed by 15 min of
staining in Gelred dye (Biotum) and detected under UV transilluminator.
Results
Of 214 tested strains, 38 carried any of PMQRs alone or in combination and
these represent 17.7% prevalence among Enterobacteriaceae. Altogether, 15
strains proved positive to any qnr determinant and among them, eight qnrS, six
Table II. Primers used in detection of virulence determinants
Primer Sequence Reference
afa fwd 5′-GCGGGCAGCAAACTGAAACTCTC-3′ [26]
afa rev 5′-CATCAAGCTGTTTGTTCGTCCGCCG-3′
sfa/foc fwd 5′-CTCCGGAGAACTGGGTGCATCTTAC-3′
sfa/foc rev 5′-CGGAGGAGTAAATTACAAACCTGGCA-3′
pap fwd 5′-GCAACAGCAACGCTGGTTGCATCAT-3′
pap rev 5′-AGAGAGAGCCACTCTTATACGGACA-3′
kpsMT fwd 5′-CCATCGATACGATCATTGCACG-3′ [27]
kpsMT rev 5′-ATTGCAAGGTAGTTCAGACTCA-3′
pil fwd 5′-CATTCGCCTGTAAAACCGCC-3′ [28]
pil rev 5′-ATAACACGCCGCCATAAGCC-3′
Note: afa: aﬁmbrial adhesions; pap: pili associated with pyelonephritis; pil: P ﬁmbria;
sfa/foc: S and F1C ﬁmbiriae; kpsMT: K-antigen.
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qnrA, two qnrD, and a single qnrB were detected. Two E. coli strains carried both
qnrA and qnrS determinants, although their ciproﬂoxacin MIC values were still at
the wild-type phenotype (0.06 mg/L). Two M. morganii strains out of ﬁve were
positive for qnrD, whereas on the other hand, four P. mirabilis strains carrried a
qnrA determinant. Altogether, 19 strains (18 K. pneumoniae and an Enterobacter
aerogenas) were positive for both oqxA and oqxB coding gene of efﬂux pump.
Moreover, 20 strains (13 E. coli, 3 Proteus mirabilis, 3 Klebsiella spp., and
1M. morganii) carried only oqxA, while 5 strains were positive only for oqxB (four
Enterobacter spp. and a K. oxytoca). In contrast, neither qepA nor qnrC resistance
determinants were found in this study. Among 23 aac(6)-Ib, PCR positive strains
BstF5I restriction enzyme analysis detected nine aac(6)-Ib-cr variant, and these
were carried by E. coli, M. morganii, Klebsiella spp., and Enterobacter spp.
(Table III).
From 38 PMQR positive strains, 25 were under the ciproﬂoxacin resistance
breakpoint of EUCAST issued in 2016 namely, 9 exhibited intermediate-resistant
phenotype (MIC 0.5–1 mg/L), 13 were still wild-type (0.06 mg/L), and 3 strains
had 0.125 mg/L ciproﬂoxacin MIC value (Figure 1), but almost all of them were
susceptible to ceftriaxone except one E. coli and two K. pneumoniae. Regarding
imipenem MICs, all were found susceptible, only low-level imipenem resistance
was common in all Proteus spp. and M. morganii strains (Table III).
Investigation of virulence determinants showed that pil gene, coding the
P ﬁmbria virulence determinant was commonly carried by each tested strain. Other
virulence factors varied among tested strains (Table IV).
Discussion
Our investigation found various PMQR determinants in a collection of 214
non-repetitive Enterobacteriaceae strains. Of 38 PMQR positve strains, 9 showed
intermediate ﬂuoroquinolone resistance phenotype, 13 were still wild-type, and 3
had 0.125 mg/L ciproﬂoxacin MIC values, and all these 25 strains were still
interpreted as susceptible after the EUCAST documents issued in 2016. EUCAST
breakpoints in 2016 considered Enterobacteriaceae strains with MIC values under
0.5 mg/L as “susceptible,” on the other hand, MIC over 1 mg/L as “resistant,” and
all in between as “intermediate” phenotype. Wild-type ﬂuoroquinolone phenotype
was MIC value ≤0.06 mg/L. However, from January 1, 2017, these data were
revised and declared 0.25 mg/L MIC value as the breakpoint of susceptibility,
while resistance was set at 0.5 mg/L. This change correlates well with our ﬁndings,
as it emphasizes the possibility of the selection of resistant strains at 0.5 mg/LMIC
value, which may occur due to presence of PMQRs.
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Furthermore, it should also be noted that numerous strains carry PMQRs at
the wild-type ﬂuoroquinolone phenotype with ciproﬂoxacin MIC 0.06 mg/L, in
these cases, PMQR determinants remain latent that can be explained by lack of
gene expression.
Table III. Plasmid-mediated quinolone resistance (PMQR) determinant positive strains, with ciproﬂoxacin,
ceftriaxone, and imipenem MIC values
Number Strain PMQRs Ciproﬂoxacin Ceftriaxone Imipenem
1 E. coli 199 qnrB 1.0 0.06 0.25
2 E. coli 193 qnrS 0.5 0.06 0.25
3 E. coli 184 qnrS 0.06 0.06 0.5
4 E. coli 180 qnrS 0.125 0.06 0.25
5 E. coli 178 qnrS 2.0 0.06 0.25
6 E. coli 177 qnrS 0.06 0.06 0.25
7 E. coli 175 qnrS, aac(6)-Ib-cr 32 128 0.25
8 E. coli 15 qnrA, qnrS 0.06 0.06 0.125
9 E. coli 38 qnrA, qnrS 0.06 0.06 0.125
10 M. morganii 10 qnrD 2.0 0.06 4.0
11 M. morganii 71 qnrD, aac(6)-Ib-cr 2.0 0.06 4.0
12 P. mirabilis 6 qnrA 4.0 0.06 2.0
13 P. mirabilis 7 qnrA 2.0 0.06 4.0
14 P. mirabilis 40 qnrA 4.0 0.06 4.0
15 P. mirabilis 42 qnrA 0.06 0.06 4.0
16 E. aerogenes oqxAB 0.125 0.06 0.25
17 K. pneumoniae oqxAB 8.0 0.25 0.25
18 K. pneumoniae oqxAB 0.06 0.5 0.25
19 K. pneumoniae oqxAB 128 0.06 0.5
20 K. pneumoniae oqxAB 0.06 0.06 0.125
21 K. pneumoniae oqxAB 0.06 0.06 0.125
22 K. pneumoniae oqxAB 0.5 0.06 0.125
23 K. pneumoniae oqxAB 0.06 0.06 0.125
24 K. pneumoniae oqxAB 0.06 128 0.25
25 K. pneumoniae oqxAB 0.125 0.5 0.25
26 K. pneumoniae oqxAB 0.06 0.25 0.25
27 K. pneumoniae oqxAB 1.0 1.0 0.25
28 K. pneumoniae oqxAB 0.06 0.06 0.25
29 K. pneumoniae oqxAB 16 0.125 0.25
30 K. pneumoniae oqxAB 0.06 0.25 0.125
31 K. pneumoniae oqxAB 0.5 1.0 0.125
32 K. pneumoniae oqxAB, aac(6)-Ib-cr 1.0 128 0.25
33 K. pneumoniae oqxAB, aac(6)-Ib-cr 2.0 0.5 0.25
34 K. pneumoniae oqxAB, aac(6)-Ib-cr 4.0 0.25 0.5
35 K. oxytoca aac(6)-Ib-cr 32 1.0 0.25
36 K. pneumoniae aac(6)-Ib-cr 1.0 0.06 0.25
37 E. kobei aac(6)-Ib-cr 1.0 0.125 0.5
38 E. cloacae aac(6)-Ib-cr 1.0 0.25 0.25
Note: All MIC values are in (mg/L).
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Our data conﬁrm that ciproﬂoxacin MIC values alone are not enough to
detect resistance; therefore, detection of PMQRs, most importantly qnr genes, is
to be conducted by molecular biological methods. According to this study,
more thorough examination could be considered in case of strains exhibiting
reduced susceptiblity and intermediate phenotype. In these cases, routine check on
presence of PMQRs could be conducted to evalute possibility of selection of
resistant strains. This study found 17.7% prevalence of PMQR-positive
Enterobacteriaceae from urine clinical sample and this is the ﬁrst report of qnrD
resistance determinant in Hungary. Earlier, investigation from Hungary showed
extended-spectrum beta-lactamase (ESBL)-producing E. coli and Klebsiella spp.,
with qnrA, qnrB, qnrS, and aac(6)-Ib-cr [29, 30]. Although we did not investigate
the correlation of PMQRs in ESBL-producing strains, but based on our results, we
can say that there is no strong correlation, as we found a total 38 strains being
PMQR positive, but among them, only three showed resistance to third generation
of cefalosporin.
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Figure 1. Ciproﬂoxacin minimum inhibitory concentration (MIC) distribution of 38 PMQR positive
strains
Table IV. Distribution of virulence determinants in the tested E. coli strains
Strain afa pap pil sfa/foc kpsMT
E.coli 15 − − + − −
E.coli 38 − + + + +
E.coli 177 − + + + +
E.coli 178 − − + − +
E.coli 180 + − + − +
E.coli 184 − − + + +
E.coli 193 − − + − +
E.coli 199 − + + + +
Note: afa: aﬁmbrial adhesions; pap: pili associated with pyelonephritis; pil: P ﬁmbria;
sfa/foc: S and F1C ﬁmbiriae; kpsMT: K-antigen.
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According to international data, the prevalence of PMQR genes, qnrA, qnrB,
qnrS, aac(6′)-Ib-cr, and qepA is associated with ESBLs, but actual prevalence of
qnrC is unknown; however, some data are released about qnrD [6, 17, 30].
In this study, we report the ﬁrst detection of qnrD determinant in Hungary,
which was found in two M. morganii strains that represent around 1% prevalence
in Enterobacteriaceae and 40% ofM. morganii. These data are in good correlation
with international data, which demonstrated qnrD determinant in clinical isolates
among species of Proteaee tribe (Proteus spp., Providencia spp., andM. morganii)
[16–18]. Our results show that P ﬁmbria is a common virulence determinant
among qnr-positive E. coli causing urinary tract infections.
Acknowledgements
The authors would like to thank Giuseppe Cornaglia (Verona, Italy) for
sending us qnrA1, qnrB1, qnrC, qnrD1, and qnrS1 control strains. This study was
ﬁnancially supported by OTKA Hungarian Scientiﬁc Fund, grant number:
108481.
Conﬂict of Interest
The authors declare no competing interests.
References
1. Martinez-Martinez, L., Pascual, A., Jacoby, G.: Quinolone resistance from transferable
plasmid. Lancet 351, 797–799 (1998).
2. Jacoby, G., Cattoir, V., Hooper, D., Martinez-Martinez, L., Nordmann, P., Pascual, A.,
Poirel, L., Wang, M.: qnr gene nomenclature. Antimicrob Agents Chemother 52, 2297–
2299 (2008).
3. Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Park, C. H., Bush,
K., Hooper, D. C.: Fluoroquinolone modifying enzyme: A new adaptation of a common
aminoglycoside acetyltransferase. Nature 12, 83–88 (2006).
4. Yamane, K., Wachino, J. I., Suzuka, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K.,
Konda, T., Arakawa, Y.: New plasmid medaited ﬂuoroquinolone efﬂux pump, Qep A,
found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51, 3354–3360
(2007).
5. Kim, H. B., Wang, M., Park, C. H., Kim, E. C., Jacoby, G., Hooper, D. C.: oqxAB encoding
a multidrug efﬂux pump in human clinical isolates of Enterobacteriaceae. Antimicrob
Agents Chemother 53, 3582–3584 (2009).
6. Rodriguez-Martinez, J. M., Cano, M. E., Velasco, C., Martinez-Martinez, L., Pascual, A.:
Plasmid-mediated quinolone resistance: An update. J Infect Chemother 17, 149–182
(2011).
PLASMID-MEDIATED QUINOLONE RESISTANCE 263
Acta Microbiologica et Immunologica Hungarica 65, 2018
7. Endimiani, A., Carias, L. L., Hujer, A. M., Bethel, C. R., Hujer, K. M., Perez, F., Hutton,
R. A., Fox, W. R., Hall, G. S., Jacobs, M. R., Paterson, D. L., Rice, L. B., Jenkins, S. G.,
Tenover, F. C., Bonomo, R. A.: Presence of plasmid-mediated quinolone resistance in
Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents
Chemother 52, 2680–2682 (2008).
8. Carattoli, A., Aschbacher, R., March, A., Larcher, C., Livermoor, D. M., Woodford, N.:
Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and
SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids
encoding KPC enzymes in the USA. J Antimicrob Chemother 65, 2070–2075 (2010).
9. Poirel, L., Van de Loo, M., Mammeri, H., Nordmann, P.: Association of plasmid-mediated
quinolone resistance with extended-spectrum beta-lactamase VEB-1. Antimicrob Agents
Chemother 49, 3091–3094 (2005).
10. Wei, D. D., Wan, L. G., Yu, Y., Xu, Q. F., Deng, Q., Cao, X. W., Liu, Y.: Characterization
of extended-spectrum beta-lactamase, carbapenemase and plasmid quinolone determinants
in Klebsiella pneumoniae isolates carrying distinct types of 16s rRNA methylase genes and
their association with mobile genetic elements. Microbial Drug Resistance 21, 186–193
(2015).
11. Perichon, B., Bogaerts, P., Lambert, T., Frangeul, L., Courvalin, P., Galimand, M.:
Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by
16s rRNA methylation and to hydrophilic ﬂuoroquinolones by efﬂux. Antimicrob Agents
Chemother 52, 2581–2592 (2008).
12. Wang, M., Guo, Q., Xu, X., Wang, X., Ye, X., Wu, S., Hooper, D. C., Wang, M.: New
plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus
mirabilis. Antimicrob Agents Chemother 53, 1892–1897 (2009).
13. Cavaco, L. M., Hasman, H., Xia, S., Aarestrup, F. M.: qnrD, a novel gene conferring
transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismor-
biﬁcans strains of human origin. Antimicrob Agents Chemother 53, 603–608 (2009).
14. Veldman, K., Cavaco, L. M., Mevius, D., Battisti, A., Franco, A., Botteldoorn, N., Bruneau,
M., Perrin-Guyomard, A., Cerny, T., de Frutos Escobar, C., Guerra, B., Schroeter, A.,
Guitterez, M., Hopkins, K., Myllyniemi, A. L., Sunde, M., Wasyl, D., Aarestrup, F. M.:
International collaborative study on the occurence of plasmid-medaited quinolone resisi-
tance in Salmonella enterica and Escherichia coli isolated from animals, humans food and
the environment in 13 European countries. J Antimicrob Chemother 66, 1278–1286 (2011).
15. Zhang, J., Chen, Z., Chen, S., Deng, Y., Liu, Y., Tian, W., Huang, X., Wu, C., Sun, Y., Sun,
Y., Zeng, Z., Liu, J. H.: Prevalence and dissemination of oqxAB in Escherichia coli isolates
from animals, farmworkers and the environment. Antimicrob Agents Chemother 54,
4219–4224 (2014).
16. Mazzariol, A., Kocsis, B., Koncan, R., Kocsis, E., Lanzafame, P., Cornaglia, G.:
Description and plasmid characterization of qnrD determinants in Proteus mirabilis and
Morganella morganii. Clin Microbiol Infect 18, E46–E48 (2012).
17. Guillard, T., Grillon, A., de Champs, C., Cartier, C., Madoux, J., Berçot, B., Lebreil, A. L.,
Lozniewski, A., Riahi, J., Vernet-Garnier, V., Cambau, E.: Mobile insertion cassette
elements found in small non-transmissible plasmids in Proteeae may explain qnrD
mobilization. PLoS One 9, e87801 (2014).
18. Guillard, T., Cambau, E., Neuwirth, C., Nenninger, T., Mbadi, A., Brasme, L., Vernet-
Garnier, V., Bajolet, O., de Champs, C.: Description of a 2, 683-base-pair plasmid
264 SZABO´ ET AL.
Acta Microbiologica et Immunologica Hungarica 65, 2018
containing qnrD in two Providencia rettgeri isolates. Antimicrob Agents Chemother 56,
565–568 (2012).
19. Albornoz, E., Tijet, N., De Belder, D., Gomez, S., Martino, F., Corso, A., Melano, R. G.,
Petroni, A.: qnrE1, a member of a new family of plasmid-located quinolone resistance
genes, originated from the chromosome of Enterobacter species. Antimicrob Agents
Chemother 61, e02555-16 (2017).
20. Cunha, M. P. V., Davies, Y. M., Cerdeira, L., Dropa, M., Lincopan, N., Knöbl, T.:
Complete DNA sequence of an IncM1 plasmid bearing the novel qnrE1 plasmid-mediated
quinolone resistance variant and bla CTX-M-8 from Klebsiella pneumoniae sequence type
147. Antimicrob Agents Chemother 61, e00592-17 (2017).
21. Cattoir, V., Poirel, L., Rotimi, V., Soussy, C. J., Nordmann, P.: Multiplex PCR for detection
of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial
isolates. J Antimicrob Chemother 60, 394–397 (2007).
22. Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A., Hooper, D. C.: qnr prevalence in
ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob
Agents Chemother 50, 2872–2874 (2006).
23. Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A., Hooper, D.:
qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob Agents Che-
mother 50, 1178–1182 (2006).
24. Yamane, K., Wachino, J. I., Suzuki, S., Arakawa, Y.: Plasmid-mediated qepA gene among
Escherichia coli clinical isolates in Japan. Antimicrob Agents Chemother 52, 1564–1566
(2008).
25. Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., Hooper, D. C.: Prevalence in the United
States of aac(6′)-Ib-cr encoding a ciproﬂoxacin-modifying enzyme. Antimicrob Agents
Chemother 50, 3953–3955 (2006).
26. Yamamoto, S., Terai, A., Yuri, K., Kurazono, H., Takeda, Y., Yoshida, O.: Detection of
urovirulence factors in Escherichia coli by multiplex polymerase chain reaction. FEMS
Immunol Med Microbiol 12, 85–90 (1995).
27. Kanamaru, S., Kurazono, H., Ishitoya, S., Terai, A., Habuchi, T., Nakano, M., Ogawa, O.,
Yamamoto, S.: Distribution and genetic association of putative uropathogenic virulence
factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract
infections in Japan. J Urol 170, 2490–2493 (2003).
28. Tseng, C. C., Huang, J. J., Ko, W. C., Yan, J. J., Wu, J. J.: Decreased predominance of papG
class 2 allele in Escherichia coli strains isolated from adults with acute pyelonephritis and
urinary tract abnormalities. J Urol 166, 1643–1646 (2001).
29. Szabo, D., Kocsis, B., Ro´kusz, L., Szentandrássy, J., Katona, K., Kristof, K., Nagy, K.: First
detection of plasmid-mediated quinolone resistance determinants qnrA, qnrB, qnrS and aac
(6)-Ib-cr in extended-spectrum beta-lactamse (ESBL)-producing Enterobacteriaceae in
Budapest, Hungary. J Antimicrob Chemother 62, 630–632 (2008).
30. Domokos, J., Kristo´f, K., Szabo´, D.: Plasmid-mediated quinolone resistance among
extended-spectrum beta-lactamase producing Enterobacteriaceae from bloodstream infec-
tions. Acta Microbiol Immunol Hung 63, 313–323 (2016).
PLASMID-MEDIATED QUINOLONE RESISTANCE 265
Acta Microbiologica et Immunologica Hungarica 65, 2018
